| Darshita Shah, MD | |
|
1825 Eastchester Rd, Bronx, NY 10461-2301 | |
| (718) 904-2767 | |
| (718) 904-2799 |
| Full Name | Darshita Shah |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 31 Years |
| Location | 1825 Eastchester Rd, Bronx, New York |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013144633 | NPI | - | NPPES |
| 252433 | Other | NY | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 252433 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Montefiore Medical Center | Bronx, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Montefiore Medical Center | 3779496021 | 2003 |
News Archive
Bioniche Life Sciences Inc., a research-based, technology driven Canadian biopharmaceutical company, today provided an update on the clinical development program for its proprietary product for non-muscle-invasive bladder cancer - Urocidin.
In this Lancet opinion piece, Laurie Garrett, a senior fellow for global health at the Council on Foreign Relations, examines a number of social, political, and financial issues at play ahead of the November 6 U.S. presidential election and their implications for domestic and global health programs.
There is still a one in eight lifetime risk that a woman will develop breast cancer, and the best tool against the disease remains early detection. Now, Women & infants Hospital of Rhode Island has taken the breast cancer battle to the next level with the installation of the most advanced imaging technology available, called digital breast tomosynthesis.
Merge Healthcare, a leading health IT solutions provider, today announced the addition of three Biotronics3D applications to its eFilm eCommerce channel: Diagnostic 3D, Vessel Review and Colon Review. Each module brings fast access to an array of advanced visualization tools that assist in non-invasive viewing and diagnosing of medical conditions.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer today announced presentations for its Aurora A/angiogenic kinase inhibitor, ENMD-2076, at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics to be held November 15-19, 2009 in Boston, Massachusetts. Presentations are listed below.
› Verified 7 days ago
| Entity Name | Montefiore Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063525152 PECOS PAC ID: 3779496021 Enrollment ID: O20031113000235 |
News Archive
Bioniche Life Sciences Inc., a research-based, technology driven Canadian biopharmaceutical company, today provided an update on the clinical development program for its proprietary product for non-muscle-invasive bladder cancer - Urocidin.
In this Lancet opinion piece, Laurie Garrett, a senior fellow for global health at the Council on Foreign Relations, examines a number of social, political, and financial issues at play ahead of the November 6 U.S. presidential election and their implications for domestic and global health programs.
There is still a one in eight lifetime risk that a woman will develop breast cancer, and the best tool against the disease remains early detection. Now, Women & infants Hospital of Rhode Island has taken the breast cancer battle to the next level with the installation of the most advanced imaging technology available, called digital breast tomosynthesis.
Merge Healthcare, a leading health IT solutions provider, today announced the addition of three Biotronics3D applications to its eFilm eCommerce channel: Diagnostic 3D, Vessel Review and Colon Review. Each module brings fast access to an array of advanced visualization tools that assist in non-invasive viewing and diagnosing of medical conditions.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer today announced presentations for its Aurora A/angiogenic kinase inhibitor, ENMD-2076, at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics to be held November 15-19, 2009 in Boston, Massachusetts. Presentations are listed below.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Darshita Shah, MD 1825 Eastchester Rd, Bronx, NY 10461-2301 Ph: (718) 904-2767 | Darshita Shah, MD 1825 Eastchester Rd, Bronx, NY 10461-2301 Ph: (718) 904-2767 |
News Archive
Bioniche Life Sciences Inc., a research-based, technology driven Canadian biopharmaceutical company, today provided an update on the clinical development program for its proprietary product for non-muscle-invasive bladder cancer - Urocidin.
In this Lancet opinion piece, Laurie Garrett, a senior fellow for global health at the Council on Foreign Relations, examines a number of social, political, and financial issues at play ahead of the November 6 U.S. presidential election and their implications for domestic and global health programs.
There is still a one in eight lifetime risk that a woman will develop breast cancer, and the best tool against the disease remains early detection. Now, Women & infants Hospital of Rhode Island has taken the breast cancer battle to the next level with the installation of the most advanced imaging technology available, called digital breast tomosynthesis.
Merge Healthcare, a leading health IT solutions provider, today announced the addition of three Biotronics3D applications to its eFilm eCommerce channel: Diagnostic 3D, Vessel Review and Colon Review. Each module brings fast access to an array of advanced visualization tools that assist in non-invasive viewing and diagnosing of medical conditions.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer today announced presentations for its Aurora A/angiogenic kinase inhibitor, ENMD-2076, at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics to be held November 15-19, 2009 in Boston, Massachusetts. Presentations are listed below.
› Verified 7 days ago
Jennifer N Lafontant, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2016 Bronxdale Ave, Suite 201, Bronx, NY 10462 Phone: 718-823-1010 | |
Dr. Carol Anne Livoti, M.D.,F.A.C.O.G. Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 2015 Grand Concourse, Bronx, NY 10453 Phone: 718-299-7295 Fax: 718-299-6797 | |
Priyanka Kadam Halani, M.D. Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 1300 Morris Park Ave, Belfer 501, Bronx, NY 10461 Phone: 718-430-3047 | |
Dr. Ndubueze Clement Job Okereke, M.D; M.P.H. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4422 3rd Ave, Bronx, NY 10457 Phone: 718-960-9415 Fax: 718-960-9414 | |
Natalie Fischer Davis, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 111 E 210th St, Bronx, NY 10467 Phone: 718-430-4031 | |
Juan E Yara, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1065 Southern Blvd, Bronx, NY 10459 Phone: 718-589-2440 Fax: 718-991-4516 |